[LITRAK] QoQ TTM Result on 31-Dec-2021 [#3]

Stock
[LITRAK] LINGKARAN TRANS KOTA HOLDINGS
Announcement Date
24-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2022
Quarter
31-Dec-2021 [#3]
Profit Trend
QoQ- -0.27%
YoY- -15.94%
Quarter Report
Latest QR
Upcoming QR
LITRAK's Result
LITRAK's Financial Summary
View:
Show?
TTM Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 489,077 438,506 400,932 384,481 367,109 413,167 392,827 15.71%
PBT 324,480 271,465 245,279 253,572 241,529 282,616 267,080 13.84%
Tax -98,921 -89,616 -82,431 -70,646 -58,103 -66,127 -61,304 37.53%
NP 225,559 181,849 162,848 182,926 183,426 216,489 205,776 6.30%
-
NP to SH 225,559 181,849 162,848 182,926 183,426 216,489 205,776 6.30%
-
Tax Rate 30.49% 33.01% 33.61% 27.86% 24.06% 23.40% 22.95% -
Total Cost 263,518 256,657 238,084 201,555 183,683 196,678 187,051 25.64%
-
Net Worth 1,376,877 1,289,131 1,212,918 1,269,985 1,205,098 1,220,851 1,181,006 10.76%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 2,547,995 79,930 133,214 133,214 106,562 106,562 106,413 729.14%
Div Payout % 1,129.64% 43.95% 81.80% 72.82% 58.10% 49.22% 51.71% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 1,376,877 1,289,131 1,212,918 1,269,985 1,205,098 1,220,851 1,181,006 10.76%
NOSH 540,272 538,799 533,083 532,868 532,868 532,843 532,843 0.92%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 46.12% 41.47% 40.62% 47.58% 49.96% 52.40% 52.38% -
ROE 16.38% 14.11% 13.43% 14.40% 15.22% 17.73% 17.42% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 90.56 81.52 75.23 72.15 68.90 77.54 73.73 14.67%
EPS 41.77 33.80 30.56 34.33 34.42 40.63 38.62 5.36%
DPS 472.00 15.00 25.00 25.00 20.00 20.00 20.00 721.18%
NAPS 2.5495 2.3964 2.2759 2.3833 2.2616 2.2912 2.2165 9.77%
Adjusted Per Share Value based on latest NOSH - 532,868
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 89.81 80.52 73.62 70.60 67.41 75.87 72.13 15.72%
EPS 41.42 33.39 29.90 33.59 33.68 39.75 37.79 6.29%
DPS 467.87 14.68 24.46 24.46 19.57 19.57 19.54 729.14%
NAPS 2.5283 2.3671 2.2272 2.332 2.2128 2.2418 2.1686 10.76%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 4.95 4.80 3.91 3.76 3.78 3.70 3.88 -
P/RPS 5.47 5.89 5.20 5.21 5.49 4.77 5.26 2.64%
P/EPS 11.85 14.20 12.80 10.95 10.98 9.11 10.05 11.59%
EY 8.44 7.04 7.81 9.13 9.11 10.98 9.95 -10.38%
DY 95.35 3.13 6.39 6.65 5.29 5.41 5.15 598.61%
P/NAPS 1.94 2.00 1.72 1.58 1.67 1.61 1.75 7.10%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 29/11/22 29/08/22 30/05/22 24/02/22 25/11/21 25/08/21 28/05/21 -
Price 0.51 4.87 4.66 3.82 3.69 3.71 3.69 -
P/RPS 0.56 5.97 6.19 5.29 5.36 4.78 5.01 -76.76%
P/EPS 1.22 14.41 15.25 11.13 10.72 9.13 9.55 -74.60%
EY 81.89 6.94 6.56 8.99 9.33 10.95 10.47 293.53%
DY 925.49 3.08 5.36 6.54 5.42 5.39 5.42 2968.24%
P/NAPS 0.20 2.03 2.05 1.60 1.63 1.62 1.66 -75.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment